SK Hynix Develops Next-Generation Mobile NAND Solution ZUFS 4.0
Mass production of industry's best-performing product for on-device AI smartphones to begin in 3Q Performance degradation over time improved, while lifetime increased by 40% SK hynix to expand leader
USARAD, Nanox's Teleradiology Subsidiary, Awarded Accreditation From The Joint Commission
Company earns Gold Seal of Approval for Ambulatory Health Care Accreditation PETACH TIKVA, Israel, May 08, 2024 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD ("Nanox" or the "Company," Nasdaq: NNOX), an in
The Joint Corp. to Participate in Upcoming Investor Conferences
SCOTTSDALE, Ariz., May 07, 2024 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ:JYNT), the nation's largest provider of chiropractic care through The Joint Chiropractic network, announced that President and Chief
Joint Is Maintained at Buy by B. Riley Securities
Joint Is Maintained at Buy by B. Riley Securities
B. Riley Securities: Maintaining the Joint (JYNT.US) rating, adjusted from a buy rating to a buy rating, and the target price was adjusted from $12.00 to $20.00.
B. Riley Securities: Maintaining the Joint (JYNT.US) rating, adjusted from a buy rating to a buy rating, and the target price was adjusted from $12.00 to $20.00.
B. Riley Securities Maintains Buy on Joint, Raises Price Target to $20
B. Riley Securities analyst Jeff Van Sinderen maintains Joint with a Buy and raises the price target from $12 to $20.
Estimating The Fair Value Of The Joint Corp. (NASDAQ:JYNT)
Key Insights The projected fair value for Joint is US$18.18 based on 2 Stage Free Cash Flow to Equity With US$16.12 share price, Joint appears to be trading close to its estimated fair value The
Earnings Call Summary | The Joint(JYNT.US) Q1 2024 Earnings Conference
The following is a summary of the The Joint Corp. (JYNT) Q1 2024 Earnings Call Transcript:Financial Performance:The Joint Corp. reported Q1 2024 system-wide sales of $126.3 million, a 9% increase year
Is The Joint Corp. (NASDAQ:JYNT) Trading At A 48% Discount?
Joint First Quarter 2024 Earnings: EPS Beats Expectations
The Joint Corp (JYNT): Hold Rating Maintained Amidst Transition and Mixed Performance
Joint Shares Are Trading Higher After the Company Reported Better-than-expected Q1 Financial Results and Reiterated FY23 System-wide Sales Guidance. Also, Roth MKM Reiterated a Buy Rating on the Stock and Raised Its Price Target From $13 to $16.
Joint Shares Are Trading Higher After the Company Reported Better-than-expected Q1 Financial Results and Reiterated FY23 System-wide Sales Guidance. Also, Roth MKM Reiterated a Buy Rating on the Stock
Roth MKM Reiterates Buy on Joint, Raises Price Target to $16
Roth MKM analyst George Kelly reiterates Joint (NASDAQ:JYNT) with a Buy and raises the price target from $13 to $16.
Joint Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/03/2024 5.61% Roth MKM $13 → $16 Reiterates Buy → Buy 09/14/2023 -14.19% Roth MKM $16 → $13 Maintains B
The Joint Corp (JYNT) Q1 2024 Earnings: Revenue Grows, Surpassing Analyst Projections
The Joint Corp. Reiterated Guidance, 2024 System-Wide Sales Expected To Be $530M-$545M
The Joint Corp. Reiterated Guidance, 2024 System-Wide Sales Expected To Be $530M-$545M
Joint Q1 2024 GAAP EPS $0.06 Beats $(0.01) Estimate, Sales $29.722M Beat $29.591M Estimate
Joint (NASDAQ:JYNT) reported quarterly earnings of $0.06 per share which beat the analyst consensus estimate of $(0.01) by 700 percent. This is a 62.5 percent decrease over earnings of $0.16 per share
Earnings Flash (JYNT) THE JOINT Posts Q1 Revenue $29.7M, Vs. Street Est of $29.6M
04:33 PM EDT, 05/02/2024 (MT Newswires) -- Earnings Flash (JYNT) THE JOINT Posts Q1 Revenue $29.7M, vs. Street Est of $29.6M
Joint 1Q EPS 6c >JYNT
Joint 1Q EPS 6c >JYNT
Press Release: The Joint Corp. Reports First Quarter 2024 Financial Results
The Joint Corp. Reports First Quarter 2024 Financial Results - Grew Q1 2024 Revenue 5%, System-wide Sales 9%, and System-wide Comp Sales 3% vs. Q1 2023 - - Opened 23 Franchised Clinics, Increasing C
No Data